Supreme Pharmaceuticals, Inc.'s ticker is and the CUSIP is 868632209. A total of 2 filers reported holding Supreme Pharmaceuticals, Inc. in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BOSTON FINANCIAL MANGEMENT LLC | 10,000 | $11,000 | 0.00% |
Vantage Investment Advisors, LLC | 200 | $0 | 0.00% |